[bibliografia] Medicina / Endocrinologia

autori anno titolo
van Dijk D, Dekker MJHJ, Conemans EB, Wiepjes CM, de Goeij EGM, Overbeek KA, Fisher AD, den Heijer M, T'Sjoen G. 2019 Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People-Results from the European Network for the Investigation of Gender Incongruence. J Sex Med. 2019 Jun 20. pii: S1743-6095(19)31213-5. doi: 10.1016/j.jsxm.2019.05.009 IF IF 4.101.
Ristori J, Cocchetti C, Castellini G, Pierdominici M, Cipriani A, Testi D, Gavazzi G, Mazzoli F, Mosconi M, Meriggiola MC, Cassioli E, Vignozzi L, Ricca V, Maggi M and Fisher AD 2019 Hormonal Treatment effect on Sexual Distress in Transgender Persons: Two-Year Follow-Up Data. 2019 J Sex Med accepted.
Tanini S, Fisher AD, Meattini I, Bianchi S, Ristori J, Maggi M, Lo Russo G. 2019 Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation. Clin Breast Cancer. 2019 Apr;19(2):e271-e275. IF 2.703.
Giovanardi, G., Morales, P., Mirabella, M., Fortunato, A., Chianura, L., Speranza, A.M., Lingiardi, V. 2019 Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty. Journal of Endocrinological Investigation. doi: 10.1007/s40618-019-01045-2 
Klaver M, de Blok CJM, Wiepjes CM, Nota NM, Dekker MJHJ, de Mutsert R, Schreiner T, Fisher AD, T'Sjoen G, den Heijer M. 2018 Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Eur J Endocrinol. 2018;178(2):165-173. IF 4.101.
Fisher AD and Gooren L. 2018 Hormonal Treatment of Transgender Male to Female. In Encyclopedia of Endocrine Diseases, 2nd Edition edited by Ilpo Huhtaniemi and Luciano Martini, 2018 Elsevier Inc. in press
Mancini I, Rotilio A, Coati I, Seracchioli R, Martelli V, Meriggiola MC. 2018 Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecol Endocrinol. 2018 Jun;34(6):456-459. doi: 10.1080/09513590.2017.1395839.
Gava G, Mancini I, Cerpolini S, Baldassarre M, Seracchioli R, Meriggiola MC. 2018 Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over five years of administration. Clin Endocrinol (Oxf). 2018 Dec;89(6):878-886. doi: 10.1111/cen.13821. Epub 2018 Aug 12.
Wiepjes CM, Vlot MC, Klaver M, Nota MN, de Blok CJM, de Jongh RT, Lips P, Heijboer AC, Fisher AD, Schreiner T, T’Sjoen T, den Heijer M. 2017 Bone mineral density increases in trans persons after one year hormonal treatment: a multicenter prospective observational study J Bone Miner. Res. 2017 Jun;32(6):1252-1260. IF 6.284.
de Blok CJM, Klaver M, Wiepjes CM, Nota NM, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M. 2017 Breast Development in Transwomen After One Year of Cross-sex Hormone Therapy: Results of A Prospective Multicenter Study. J Clin Endocrinol Metab. 2017 Nov 20. doi: 10.1210/jc.2017-0192. IF 5.455.
Fisher AD 2017 Disforia di Genere e Transessualismo.. La salute della Coppia. Libro bianco sullo stato dell’assistenza in medicina della sessualità e in Andrologia in Italia. SIAMS: Emanuele A. Jannini, Andrea Lenzi, Carlo Foresta, Mario Maggi, Alberto Ferlin, Antonio Aversa. Febbraio 2017
Vitelli, R., Scandurra, C., Pacifico, R., Selvino, M. S., Picariello, S., Amodeo, A. L., Valerio, P., & Giami A. 2017 Identifications de genre trans et pratiques médicales en Italie : positionnement personnel envers les formes de chirurgie de confirmation de genre. Sexologies, vol. 26, p. 199-204, ISSN: 1158-1360, doi: 10.1016/j.sexol.2017.08.002.
Meriggiola MC., Gava G. 2017 Terapia medica della disforia di genere: individui Female-to-Male. In Sessuologia medica - Trattato di psicosessuologia e medicina della sessualità. Jannini EA., Lenzi A., Maggi MA. 2^ ed. Edra editore. 2017, pp 481-484. EAN: 9788821439223.
Fisher AD, Ristori J, Morelli G, Maggi M. 2017 The molecular mechanisms of sexual orientation and gender identity. Mol Cell Endocrinol. 2017 Aug 25. pii: S0303-7207(17)30430-6. doi: 10.1016/j.mce.2017.08.008. [Epub ahead of print] Review. IF 3.754.
Gava G, Seracchioli R, Meriggiola MC. 2017 Therapy with Anti-androgens in Gender Dysphoric Natal Males. Endocrinology of the Testis and Male Reproduction. Simoni M, Huhtaniemi I. Part of the series Endocrinology pp 1-11. February 2017
Vitelli, R., Scandurra, C., Pacifico, R., Selvino, M. S., Picariello, S., Amodeo, A. L., Valerio, P., & Giami A. 2017 Trans identities and medical practice in Italy: Self-positioning towards gender affirmation surgery. Sexologies, 26, e43—e51. Doi:10.1016/j.sexol.2017.08.001.
Defreyne J, Nota N, Perreira C, Schreiner T, Fisher AD, Den Heijer M, T’Sjoen G. 2017 Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment. LGBT Health. 2017;4(5):328-336. IF 2.053.
Dekker MJ, Wierckx K, Van Caenegem E, Klaver M, Kreukels BP, Elaut E, Fisher AD, van Trotsenburg MA, Schreiner T, den Heijer M, T'Sjoen G. 2016 A European Network for the Investigation of Gender Incongruence: Endocrine Part. J Sex Med. 2016;13(6):994-9. IF 3.151.
Fisher AD, Castellini G, Ristori J, Casale E, Cassioli E, Sensi C, Fanni E, Amato ML, Bettini E, Dèttore D, Ricca V, Maggi M. 2016 Cross-sex hormone treatment and psychobiological changes in transsexual persons:2-yr follow-up data. J Clin Endocrinol Metab. 2016;101(11):4260-4269. IF 5.455.
Gava G, Cerpolini S, Martelli V, Battista G, Seracchioli R, Meriggiola MC. 2016 Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clin Endocrinol (Oxf). 2016 Aug;85(2):239-46. doi: 10.1111/cen.13050. Epub 2016 Mar 21. PubMed PMID: 26932202.
Fisher AD, Ristori J, Fanni E, Castellini G, Forti G, Maggi M. 2016 Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major dilemma. Review J Endocrinol Invest. 2016;39(11):1207-1224. IF 2.633.
Fisher AD, Amato AML, Meriggiola MC, Gava G, Motta G, Manieri C. 2016 Problematiche endocrine della Disforia di Genere. Endocrinologo 2016; 17:1-9
Seal LJ. 2015 A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Ann Clin Biochem. 2015 May 1. [Epub ahead of print]
Meriggiola MC, Gava G, 2015 Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. Clin Endocrinol (Oxf). 2015 Feb 18. [Epub ahead of print]
Meriggiola MC, Gava G. 2015 Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen. Clin Endocrinol (Oxf). 2015 Feb 18. [Epub ahead of print]
Fisher A.D. and Mario Maggi 2015 Endocrine treatment of transsexual MtoF persons. In Management of Gender Identity Dysphoria: A Multidisciplinary Approach to Transsexualism Editors. C. Trombetta, G. Liguori, M. Bertolotto, Editors. C. 83-91 Springer Milan, 2015. DOI 10.1007/978-88-470-5696-1
Fisher AD, Castellini G, Casale H, Fanni E, Bandini E, Campone B, Ferruccio N, Maseroli E, Boddi V, Dèttore D, Pizzocaro A, Balercia G, Oppo A, Ricca V, Maggi M. 2015 Hypersexuality, Paraphilic Behaviors, and Gender Dysphoria in Individuals with Klinefelter's Syndrome. J Sex Med. 2015;12(12):2425-35. IF 3.151.
Fisher A.D., Amato A.M.L., Maggi M. 2015 Identità di genere e Assegnazione di genere in soggetti con Disordine della Differenziazione sessuale. Capitolo 2, pagine 49-38, Disforia di genere in età evolutiva. Dèttore D, Ristori J, Antonelli P. Ed. Alpes, 2015.
Risso, R., Einaudi, S., Crespi, C., Caldarera, A., Verna, F., Merlini, E., Lala, R. 2015 Sex attribution, gender identity and quality of life in disorders of sex development due to 45,X/46,XY mosaicism: methods for clinical and psychosocial assessment. AIMS Genetics 2(2).
EPATH 2015 TRANSGENDER HEALTH CARE IN EUROPE, Book of Abstract (2015)
Fisher AD, Castellini G, Bandini E, Casale H, Fanni E, Benni L, Ferruccio N, Meriggiola MC, Manieri C, Gualerzi A, Jannini E, Oppo A, Ricca V, Maggi M, Rellini AH. 2014 Cross-Sex Hormonal Treatment and Body Uneasiness in Individuals with Gender Dysphoria. J Sex Med. 2014;11(3):709-19. IF 3.151.
Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher A, Toye K, Kaufman JM, T'Sjoen G. 2014 Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med. 2014 Aug;11(8):1999-2011.
Cunha FS, Domenice S, Câmara VL, Sircili MH, Gooren LJ, Mendonça BB, Costa EM. 2014 Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy. Andrologia. 2014 Jul 25. [Epub ahead of print]
Pelusi C, Costantino A, Martelli V, Lambertini M, Bazzocchi A, Ponti F, Battista G, Venturoli S, Meriggiola MC. 2014 Effects of three different testosterone formulations in female-to-male transsexual persons. J Sex Med. 2014 Dec;11(12):3002-11. doi: 10.1111/jsm.12698. Epub 2014 Sep 24. PubMed PMID: 25250780.
Klink, D., & Den Heijer, M. 2014 Genetic Aspects of Gender Identity Development and Gender Dysphoria. In Kreukels, Baudewijntje P.C., Steensma, Thomas D., de Vries, Annelou L.C (eds.), Gender Dysphoria and Disorders of Sex Development, 25-51. Springer US.
Fisher AD, Ristori J, Bandini E, Giordano S, Mosconi M, Jannini EA, Greggio NA, Godano A, Manieri C, Meriggiola C, Ricca V; 2014 Italian GnRH analogs study ONIG group, Dettore D, Maggi M Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG..J Endocrinol Invest. 2014 Jul;37(7):675-87. doi: 10.1007/s40618-014-0077-6. Epub 2014 May 27.
Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. 2014 Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014; 124: 1120-1127.
Costantino A, Cerpolini S, Alvisi S, Morselli PG, Venturoli S, Meriggiola MC. 2013 A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. J Sex Marital Ther. 2013;39(4):321-35. doi: 10.1080/0092623X.2012.736920. Epub 2013 Mar PubMed PMID: 23470169.
Gooren LJ, Van Trotsenburg MA, Giltay EJ, van Diest PJ. 2013 Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med. 2013; 10: 3129–3134.
Hembree WC. 2013 Management of juvenile gender dysphoria. Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):559-64.
Meriggiola MC, Berra M. 2013 Safety of hormonal treatment in transgenders. Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):565-9. doi:10.1097/01.med.0000436187.95351.a9. Review. PubMed PMID: 24468759.
Fisher AD, Bandini E, Casale H, Ferruccio, N, Meriggiola M, Gualerzi A, Manieri C, Jannini EA, Mannucci E, Monami M, Stomaci N, Delle Rose A, Susini T, Ricca V, Maggi M. 2013 Sociodemographic and Clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med. 2013;10(2):408-19. IF 3.151.
Di Sante S, Fisher AD, Lenzi A, Jannini EA. 2013 Terapia ormonale del transessualismo.’Endocrinologo, Ottobre 2013, vol 14, no 5
Erickson-Schroth, 2013 Update on the Biology of Transgender Identity, Journal of Gay & Lesbian Mental Health, 17:2, 150-174
Kreukels, B. P., Haraldsen, I. R., De Cuypere, G., Richter-Appelt, H.,Gijs, L., & Cohen-Kettenis, P. T. 2012 A European network for the investigation of gender incongruence: The ENIGI initiative.European Psychiatry, 27, 445–450.
Rametti, G., Carrillo, B., G´omez-Gil, E., Junque, C., Zubiarre-Elorza, L., Segovia,S., Guillamon, A. 2012 Effects of androgenization on the white matter microstructure of female-to-male transsexuals: A diffusion tensor imaging study.Psychoneuroendocrinology, 37, 1261–1269.
Gómez-Gil E, Zubiaurre-Elorza L, Esteva I, Guillamon A, Godás T, Cruz Almaraz M, Halperin I, Salamero M. 2012 Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology 2012;37: 662–70.
Gorin-Lazard, A., Baumstarck, K., Boyer, L., Maquigneau, A., Gebleux, S., Penochet, J.-C., … Bonierbale, M. 2012 Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. The journal of sexual medicine, 9(2), 531–41.
Meriggiola MC, Berra M. 2012 Long-term cross-sex hormone treatment is safe in transsexual subjects. Asian J Androl. 2012 Nov;14(6):813-4. doi: 10.1038/aja.2012.89. Epub 2012 Aug 27. PubMed PMID: 22922319; PubMed Central PMCID: PMC3720111.
Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, et al. 2012 Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012 9: 2641–2651.
Kreukels, B. P. C., & Cohen-Kettenis, P. T. 2012 Male gender identity and masculine behavior; the role of sex hormones in brain development. In M. Maggi (Ed.), Hormonal therapy for male sexual dysfunction (pp. 1–10). West Sussex, UK: Wiley.
Wierckx K, Stuyver I, Weyers S, Hamada A, Agarwal A, De Sutter P, T’Sjoen G. 2012 Sperm Freezing in Transsexual Women. Arch Sex Behav 2012 a; 41: 1069-1071.
Asscheman H, Giltay FJ, Megens J, de Ronde W, Trotsenburg MA. 2011 A long term follow up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011; 164: 635-642.
Corsello, S. M., Di Donna, V., Senes, P., Luotto, V., Ricciato, M. P., Paragliola, R. M., & Pontecorvi, A. 2011 Biological aspects of gender disorders. Minerva Endocrinologica, 36, 325–339.
Fisher AD, Bandini E, Forti G, Maggi M. 2011 Diagnosi e terapia degli Stati intersessuali in adolescenza: diagnosi e terapia. Endocrinologo aprile 2011 vol.12, num. 2
Fisher AD, Bandini E, Forti G, Maggi M. 2011 Diagnosi e terapia degli Stati intersessuali in adolescenza: diagnosi e terapia. Endocrinologo aprile 2011 vol.12, num. 2
Garcia-Falgueras, A., Ligtenberg, L., Kruijver, F. P., & Swaab, D. F. 2011 Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age and gender identity. Journal of Comparative Neurology, 519, 3061–3084.
Hembree WC. 2011 Guidelines for pubertal suspension and gender reassignment for transgender adolescents. Child Adolesc Psychiatr Clin N Am. 2011 Oct;20(4):725-32.
Urban RR, Teng NN, Kapp DS. 2011 Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Am J Obstet Gynecol. 2011; 204: e9–e12.
Inoubli, A., De Cuypere, G., Rubens, R., Heylens, G., Elaut, E., Van Caenegem, E.,T’Sjoen, G. 2011 Karyotyping, is it worthwhile in transsexualism? Journal of Sexual Medicine, 8, 475–478.
T’Sjoen, G., De Cuypere, G., Monstrey, S., Hoebeke, P., Freedman, F. K., Appari, M.,Cools, M. 2011 Male gender identity in complete androgen insensitivity syndrome. Archives of Sexual Behavior, 40, 635–638.
VanderLaan DP, Vasey PL. 2011 Male sexual orientation in independent Samoa: Evidence for fraternal birth order and maternal fecundity effects. Archives of Sexual Behavior; 40:495–503.
Hines, M. 2011 Prenatal endocrine influences on sexual orientation and on sexually differentiated childhood behavior. Front Neuroendocrinology, 32, 170–182.
Berenbaum, S. A., & Beltz, A. M. 2011 Sexual differentiation of human behavior: Effects of prenatal and pubertal organizational hormones. Frontiers in Neuroendocrinology, 32, 183–200.1
Ngun, T. C., Ghahramani, N., Sanchez, F. J., Bocklandt, S., & Vilain, E. 2011 The genetics of sex differences in brain and behavior. Frontiers in Neuroendocrinology, 32, 227–246.
Rametti, G., Carrillo B., G´omez-Gil E., Junque C., Zubiarre-Elorza L., Segovia S.,Guillamon, A. 2011 The microstructure of white matter in male to female transsexuals before cross-sex hormonal treatment. A DTI study. J Psychiatric Res 45, 949–54.
Caldarera, A., & Pfäfflin, F. 2011 Transsexualism and Sex Reassignment Surgery in Italy. International Journal of Transgenderism, 13(1), 26–36.
Veale, J. F., Clarke, D. E., & Lomax, T. C. 2010 Biological and psychosocial correlates of adult gender-variant identities: New findings. Personality and Individual Differences, 49, 252–257.
Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM. 2010 Effect of sex steroid use on cardiovascular risk in transsexuals individuals: a systemic review and meta-analysis. Clin Endocrinol. 2010; 72: 1-10.
Meriggiola MC, Jannini EA, Lenzi A, Maggi M, Manieri C. 2010 Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. Eur J Endocrinol. 2010 May;162(5):831-3.
Otto J, Kaufmann U, Bentz E, Huber JC, Tempfer CB. 2010 Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil Steril. 2010; 93: 1267-1272.
Nawata, H., Ogomori, K., Tanaka, M., Nishimura, R., Urashima, H., Yano, R., Kuwabara, Y. 2010 Regional cerebral blood flow changes in female to male gender identity disorder. Psychiatry & Clinical Neurosciences, 64, 157–161.
Rametti, G., Carrillo, B., G´omez-Gil, E., Junque, C., Segovia, S., Gomez, A., & Guillamon, A. 2010 White matter microstructure in female to male transsexuals before cross-sex hormonal treatment: A diffusion tensor imaging study. Journal of Psychiatric Research, 45, 199–204.
Hare, L., Bernard, P., S´anchez, F. J., Baird, P. N., Vilain, E., Kennedy, T., & Harley, V. R. 2009 Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biological Psychiatry, 65, 93–96.
Ujike, H., Otani, K., Nakatsuka, M., Ishii, K., Sasaki, A., Oishi, T.,Kuroda, S. 2009 Association study of gender identity disorder and sex hormonerelated genes. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33, 1241–1244.
Gooren L & Lips P. 2009 Conjectures concerning cross-sex hormone treatment of aging transsexual persons. J Sex Med. 2014; 11(8): 2012-2019.
Godano A, Maggi M, Jannini E, Meriggiola MC, Ghigo E, Todarello O, Lenzi A, Manieri C. SIAMS-ONIG 2009 Consensus on hormonal treatment in gender identity disorders. J Endocrinol Invest. 2009; 32(10): 857-864.
Bandini E, Fisher AD, Ricca V, Buci L, Ferruccio N, Ristori J, Lo Sauro C, Forti Gi, Maggi 2009 Disturbo d’identità di genere: aspetti generali e principi di diagnosi e terapia. M. L’Endocrinologo. Dicembre 2009 vol.10.no 4.
Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori V. 2009 Endocrine treatment of transsexuals persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009; 94: 3132-3154.
Kraemer, B., Noll, T., Delsignore, A., Milos, G., Schnyder, U., & Hepp, U. 2009 Finger length ratio (2D:4D) in adults with gender identity disorder. Archives of Sexual Behavior, 38, 359–363.
Wallien, M. S. C., Zucker, K. J., Steensma, T. D., & Cohen-Kettenis, P. T. 2008 2D:4D finger-length ratios in children and adults with gender identity disorder. Hormones & Behavior, 54,
Bentz, E.-K., Hefler, L. A., Kaufmann, U., Huber, J. C., Kolbus, A., & Tempfer, C. B. 2008 A polymorphism of the CYP17 gene related to sex steroid metabolism is associated with female-to-male but not male-to-female transsexualism. Fertility and Sterility, 90, 56–59.
Garcia-Falgueras, A., & Swaab, D. F. 2008 A sex difference in the hypothalamic uncinate nucleus: Relationship to gender identity. Brain, 131, 3132–3146.
Bandini E, Fisher AD, Buci L, Forti G Maggi M 2008 Il disturbo di identità di genere. XII Corso Post Specialistico di Aggiornamento in Endocrinologia Clinica, Rimini, 24-26 gennaio 2008 – Abstract book.
Gooren LJ, Giltay EJ, Bunck MC. 2008 Long term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008; 93: 19-25.
Mueller, A., Gooren, L. J., Naton-Sch¨otz, S., Cupisti, S., Beckmann, M. W., & Dittrich, R. 2008 Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. Journal of Clinical Endocrinology & Metabolism, 93, 1408–1411.
Gooren LJ & Giltay EJ. 2008 Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. J Sex Med. 2008; 5: 765–776.
Bentz, E.-K., Schneeberger, C., Hefler, L. A., van Trotsenburg, M., Kaufmann, U., Huber, J. C., & Tempfer, C. B. 2007 A common polymorphism of the SRD5A2 gene and transsexualism. Reproductive Sciences, 14, 705–709.
Baba, T., Endo, T., Honnma, H., Kitajima, Y., Hayashi, T., Ikeda, H.Saito,T. 2007 Association between polycystic ovary syndrome and female-to-male transsexuality. Human Reproduction, 22, 1011–1016
Auyeung, B., Baron-Cohen, S., Chapman, E., Knickmeyer, R., Taylor, K., & Hackett, G. 2006 Foetal testosterone and the child systemizing quotient. European Journal of Endocrinology, 155(1), 123–130. DOI: http://dx.doi.org/10.1530/eje.1.02260
Van Beijsterveldt, C. E. M., Hudziak, J. J., & Boomsma, D. I. 2006 Genetic and environmental influences on cross-gender behavior and relation to behavior problems: A study of Dutch twins at ages 7 and 10 years. Archives of Sexual behavior, 35(6), 647-658.
Hulshoff Pol H.E. 2006 Genetic Contributions to Human Brain Morphology and Intelligence. The Journal of Neuroscience, 26 (40):10235–10242
Dahl, M., Feldman, J.L., Golberg, J.M., Jaberi, A. 2006 Physical aspects of Transgender endocrine therapy. International Journal of Transgenderism, 9, 111-134.
Gooren, L. 2006 The biology of human psychosexual differentiation. Hormones and behavior, 50(4), 589–601.
Schneider, H. J., Pickel, J., & Stalla, G. K. 2006 Typical female 2nd–4th finger length (2D:4D) ratios in male-to-female transsexuals—possible implications for prenatal androgen exposure. Psychoneuroendocrinology, 31, 265–269.
Dessens, Slijper, Drop, 2005 Gender disphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behavior; 34 (4), 389-97
Meyer-Bahlburg, H. F. L. 2005 Gender identity outcome in female-raised 46, XY persons with penile agenesis, cloacal exstrophy of the bladder, or penile ablation. Archives of Sexual Behavior, 34, 423–438.
Chianura L., Ravenna A. R.: 2005 Riflessioni sul percorso di adeguamento psicofisico e legale nel disturbo dell’identità di genere presso il SAIFIP, in (a cura di) D. Dettore Il disturbo dell’identità di genere: diagnosi, eziologia, trattamento, McGraw - Hill 2005.
Henningsson, S., Westberg, L., Nilsson, S., Lundstr¨om, B., Ekselius, L., Bodlund, O., Land´en, M. 2005 Sex steroid-related genes and male-to-female transsexualism. Psychoneuroendocrinology, 30,657–664.
Elbers JM1, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, Gooren LJ. 2003 Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf). 2003 May;58(5):562-71.
World Professional Association for Transgender Health 2003 Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People. Disponibile presso http://www.wpath.org/documents/SOC%20V7%2003-17-12.pdf
Chianura L, Lo Bello D.: 2002 Le perversioni del sistema legislativo-penitenziario nei confronti delle persone transessuali e transgender, in Quale Psicologia, 20, suppl. n° 2, 2002.
Van Goozen, Stephane H. M.; Slabbekoorn, Ditte; Gooren, Louis J. G.; Sanders, Geoff; Cohen-Kettenis, Peggy T. 2002 Organizing and activating effects of sex hormones in homosexual transsexuals.Behavioral Neuroscience, Vol 116(6), 982-988.
Chung, W. C., De Vries, G. J., & Swaab, D. F. 2002 Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. Journal of Neuroscience, 22, 1027–1033.
Coolidge FL, Thede LL, Young SE. 2002 The heritability of gender identity disorder in a child and adolescent twin sample. Behavior Genetics, 32:251–257.
Esteva de Antonio, I., Giraldo, F., Bergero de Miguel, T., Cano Oncala, G., Crespillo Gomez, C., & Ruız de Adana, S. 2001 Evaluacion endocrinologica y tratamiento hormonal de la transexualidad en la Unidad de Trastornos de Identidad de Genero en Andalucıa (Malaga) [Endocrinological evaluation and hormone treatment of transsexuality by the Andalusian gender identity disorder . Cirugıa Plastica Ibero-latinoamericana, 27, 273–280.
Kruijver, F. P. M., Zhou, J. N., Pool, C. W., Hofman, M. A., Gooren, L. J. G., & Swaab, D. F. 2000 Male-to-female transsexuals have female neuron numbers in a limbic nucleus. Journal of Clinical Endocrinology & Metabolism, 85, 2034–2041.
Bosinski, H. A. G., Peter, M., Bonatz, G., Arndt, R., Sippell, W. G., & Wille, R. 1997 A higher rate of hyperandrogenic disorders in female-to-male transsexuals. Psychoneuroendocrinology, 22, 361–380.
Van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG. 1997 Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol. 1997; 47: 337-342.
Collaer, M. L., and Hines, M. 1995 Human behavioral sex differences: A role for gonadal hormones during early development? Psychol. Bull. 118, 55–107
Balen, A. H., Schachter, M. E., Montgomery, D., Reid, R. W., & Jacobs, H. S. 1993 Polycystic ovaries are a common finding in untreated female to male transsexuals. Clinical Endocrinology, 38, 325–329.
Pache, T. D., & Fauser, B. C. J. M. 1993 Polycystic ovaries in female-to-male transsexuals. Clinical Endocrinology, 39, 702–703.
Asscheman H, Gooren L, Eklund P. 1989 Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism. 1989; 38:869–873.
Futterweit, W., Weiss, R. A., & Fagerstrom, R. M. 1986 Endocrine evaluation of 40 female-to-male transsexuals: Increased frequency of polycystic ovarian disease in female transsexualism. Archives of Sexual Behavior, 15,69–78.
Money J., 1975 Ablatio penis: Normal male infant sex-reassigned as girl, Archives of Sexual Behaviour, 4, 65-71
Money, j.,& Ehrhardt, A.A. 1972 Man & Woman, Boy & Girl, the differentiation and dismorphism of gender identity from conception to maturity. Baltimora: The John Hopkins University Press.
Green, R., & Stoller, R. J. 1971 Two monozigotic (identical) twin pairs discordant for gender identity. Archives of Sexual Behavior, 1, 321-327.
Fisher AD, Casale H, Castelli G, Maggi M.   Identità sessuale. In: Gender-related health in Tuscany. pp.113-115 - ISBN:978-88-909279-0-4 Abbate R, Bruni V, Buselli R, Di Tommaso MR, Fisher AD, Maggi M, Mazzei T, Villari D.